180 related articles for article (PubMed ID: 15718417)
1. Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway.
Deriano L; Guipaud O; Merle-Béral H; Binet JL; Ricoul M; Potocki-Veronese G; Favaudon V; Maciorowski Z; Muller C; Salles B; Sabatier L; Delic J
Blood; 2005 Jun; 105(12):4776-83. PubMed ID: 15718417
[TBL] [Abstract][Full Text] [Related]
2. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase.
Amrein L; Loignon M; Goulet AC; Dunn M; Jean-Claude B; Aloyz R; Panasci L
J Pharmacol Exp Ther; 2007 Jun; 321(3):848-55. PubMed ID: 17351105
[TBL] [Abstract][Full Text] [Related]
3. Biochemical evidence for Ku-independent backup pathways of NHEJ.
Wang H; Perrault AR; Takeda Y; Qin W; Wang H; Iliakis G
Nucleic Acids Res; 2003 Sep; 31(18):5377-88. PubMed ID: 12954774
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of DNA double strand break repair and chromosome aberration formation.
Iliakis G; Wang H; Perrault AR; Boecker W; Rosidi B; Windhofer F; Wu W; Guan J; Terzoudi G; Pantelias G
Cytogenet Genome Res; 2004; 104(1-4):14-20. PubMed ID: 15162010
[TBL] [Abstract][Full Text] [Related]
5. A new phosphorylated form of Ku70 identified in resistant leukemic cells confers fast but unfaithful DNA repair in cancer cell lines.
Bouley J; Saad L; Grall R; Schellenbauer A; Biard D; Paget V; Morel-Altmeyer S; Guipaud O; Chambon C; Salles B; Maloum K; Merle-Béral H; Chevillard S; Delic J
Oncotarget; 2015 Sep; 6(29):27980-8000. PubMed ID: 26337656
[TBL] [Abstract][Full Text] [Related]
6. Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation.
Ayene IS; Ford LP; Koch CJ
Mol Cancer Ther; 2005 Apr; 4(4):529-36. PubMed ID: 15827325
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L
Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813
[TBL] [Abstract][Full Text] [Related]
8. Suppression of DNA-PKcs and Ku80 individually and in combination: Different effects of radiobiology in HeLa cells.
Zhuang L; Cao Y; Xiong H; Gao Q; Cao Z; Liu F; Qiu H; Yu S; Huang X
Int J Oncol; 2011 Aug; 39(2):443-51. PubMed ID: 21573502
[TBL] [Abstract][Full Text] [Related]
9. KU70/80, DNA-PKcs, and Artemis are essential for the rapid induction of apoptosis after massive DSB formation.
Abe T; Ishiai M; Hosono Y; Yoshimura A; Tada S; Adachi N; Koyama H; Takata M; Takeda S; Enomoto T; Seki M
Cell Signal; 2008 Nov; 20(11):1978-85. PubMed ID: 18674614
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphatases regulate DNA-dependent protein kinase activity.
Douglas P; Moorhead GB; Ye R; Lees-Miller SP
J Biol Chem; 2001 Jun; 276(22):18992-8. PubMed ID: 11376007
[TBL] [Abstract][Full Text] [Related]
11. A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia.
Willmore E; de Caux S; Sunter NJ; Tilby MJ; Jackson GH; Austin CA; Durkacz BW
Blood; 2004 Jun; 103(12):4659-65. PubMed ID: 15010369
[TBL] [Abstract][Full Text] [Related]
12. Wortmannin inhibits repair of DNA double-strand breaks in irradiated normal human cells.
Okayasu R; Suetomi K; Ullrich RL
Radiat Res; 1998 May; 149(5):440-5. PubMed ID: 9588354
[TBL] [Abstract][Full Text] [Related]
13. Interactive competition between homologous recombination and non-homologous end joining.
Allen C; Halbrook J; Nickoloff JA
Mol Cancer Res; 2003 Oct; 1(12):913-20. PubMed ID: 14573792
[TBL] [Abstract][Full Text] [Related]
14. DNA end-joining catalyzed by human cell-free extracts.
Baumann P; West SC
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14066-70. PubMed ID: 9826654
[TBL] [Abstract][Full Text] [Related]
15. Differential etoposide sensitivity of cells deficient in the Ku and DNA-PKcs components of the DNA-dependent protein kinase.
Jin S; Inoue S; Weaver DT
Carcinogenesis; 1998 Jun; 19(6):965-71. PubMed ID: 9667732
[TBL] [Abstract][Full Text] [Related]
16. Radiosensitizer effect of wortmannin in radioresistant bladder tumoral cell lines.
Ortiz T; Lopez S; Burguillos MA; Edreira A; Piñero J
Int J Oncol; 2004 Jan; 24(1):169-75. PubMed ID: 14654954
[TBL] [Abstract][Full Text] [Related]
17. A nonhomologous end-joining pathway is required for protein phosphatase 2A promotion of DNA double-strand break repair.
Wang Q; Gao F; Wang T; Flagg T; Deng X
Neoplasia; 2009 Oct; 11(10):1012-21. PubMed ID: 19794960
[TBL] [Abstract][Full Text] [Related]
18. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining.
Douglas P; Gupta S; Morrice N; Meek K; Lees-Miller SP
DNA Repair (Amst); 2005 Aug; 4(9):1006-18. PubMed ID: 15941674
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting DNA-PKcs in a non-homologous end-joining pathway in response to DNA double-strand breaks.
Dong J; Zhang T; Ren Y; Wang Z; Ling CC; He F; Li GC; Wang C; Wen B
Oncotarget; 2017 Apr; 8(14):22662-22673. PubMed ID: 28186989
[TBL] [Abstract][Full Text] [Related]
20. Activation of the DNA-dependent protein kinase by drug-induced and radiation-induced DNA strand breaks.
Mårtensson S; Nygren J; Osheroff N; Hammarsten O
Radiat Res; 2003 Sep; 160(3):291-301. PubMed ID: 12926987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
